About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
How I Treat ALK+ NSCLC With ALK TKis in 2021: Alectinib, Crizotinib, Ceritinib, Brigatinib, Ensartinib & Lorlatinib Efficacy Comparison, Acquired Resistance
By
Joshua Reuss
23 Videos
770 views
March 18, 2021
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
35:40
Balazs Halmos
Year in Review: Lung Cancer
27:04
Fengting Yan
Cancer Screening Molecular Tools
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
08:49
David Carbone
The Use of IO Doublet in PD-L1-Negative NSCLC
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …
Feat.
E. Rodriguez
07:43
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…
Feat.
P. Janne
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang
20:52
Total Health
Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…
Feat.
T. Boyle
14:49
Vivek Subbiah
Year in Review: Precision Medicine
16:12
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
Feat.
R. Osarogiagbon
05:02
GRACE
Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC
Feat.
A. Desai
23:32
2023 West Oncology Conference
2023 Updates on Neoadjuvant and Adjuvant NSCLC
Feat.
M. Johnson
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
11:50
GRACE
The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies
Feat.
J. Rotow
22:57
Total Health
Lung Cancer Screening - Best of Lung 2023
Feat.
C. Olazagasti
20:27
Yale Cancer Center
Progress in the Treatment of NSCLC
Feat.
R. Herbst
08:30
Insights from 2023 ESMO Annual Meeting
PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…
Feat.
N. Girard
54:26
Yale Cancer Center
Year in Review: Progress in NSCLC Treatment
Feat.
R. Herbst
